home / stock / eltp / eltp news


ELTP News and Press, Elite Pharmaceuticals Inc. From 08/15/23

Stock Information

Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com

Menu

ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) Q1 2024 Earnings Call Transcript

2023-08-15 15:55:06 ET Elite Pharmaceuticals, Inc. (ELTP) Q1 2024 Results Conference Call August 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Presentation Operator Good morning, ladies and gentlemen, a...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, August 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic pr...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023

Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, annou...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) Q4 2023 Earnings Call Transcript

2023-06-30 14:47:06 ET Elite Pharmaceuticals, Inc. (ELTP) Q4 2023 Earnings Conference Call June 30, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Conference Call Participants Presentation Operator G...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended Ma...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023

Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that ...

ELTP - Elite Pharmaceuticals gets new finance chief

2023-05-03 06:18:30 ET Specialty pharmaceutical company, Elite Pharmaceuticals ( OTCQB:ELTP ) appoints Mark Pellegrino as its CFO, effective May 1, 2023. Pellegrino joins Elite with more than 30 years of experience in financial and operational leadership, primarily in the...

ELTP - Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / May 3, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today announced the appointment of Mark Pellegrino as its Chief Financial Officer (CFO), effecti...

ELTP - Elite Pharmaceuticals seeks FDA approval for generic antimetabolite drug

2023-04-20 06:47:53 ET Elite Pharmaceuticals ( OTCQB:ELTP ) filed an application to the U.S. Food and Drug Administration (FDA) seeking approval for an undisclosed generic drug in a class of medicines called antimetabolites. The company said that IQVIA reported annual sales for th...

ELTP - Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product

NORTHVALE, NJ / ACCESSWIRE / April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administrati...

Previous 10 Next 10